2013 Artemisinin Conference Agenda

Day 1, 15th January

Time

 

Session

 

Speakers/Chairs

8.00 - 9.00

 

Registration

   

9.00 - 9.15

 

Opening remarks, objectives and conference format/housekeeping

   

9.15 - 9.30

 

Welcome and official opening

 

9.30 - 10.00

 

Keynote address

 
       

Chair - Jan Van Erps

10.00 - 11.00

 

Global Fund/AMFm – The Future
Reports on the outcome of the Global Fund/AMFm Board Meeting (Nov 2012)

 

11.00 - 11.30

 

Tea/coffee break

   
       

Chair - Malcolm Cutler

11.30 - 12.00

 

Semi-Synthetic Artemisinin (SSA) - Progress Report

 

12.00 - 13.00

 

Country Reports on 2012 Artemisinin Production and Market Observations

 

13.00 - 14.00

 

Lunch

   

14.00 - 14.10

 

Introduction to UNITAID

 

Chair - Alexandra Cameron UNITAID

14.10 - 15.10

 

Panel Disucussion between ACT/API Manufacturers and Procurement Representatives on: ACT Demand, today and tomorrow

 

15.10 - 15.40

 

Demand Forecast ACTs

 

15.40 - 16.15

 

Artemisinin Supply, Costing and Pricing

 

16.15 - 16.45

 

Tea/Coffee Break

   

16.45 - 17.05

 

Update on the status of Artemisinin Resistance

 

17.05 - 17.35

 

Regulatory issues concerning SSA for end users, e.g. API manufacturers

 

 

Day 2, 16th January

Time

 

Session

 

Speakers/Chair

       

Chair – Fabienne Jouberton

9.00 - 9.15

 

Flow Chemistry Semi-synthetic Artemisinin Project Progress Report

 

9.15 - 9.30

 

Synriam - arteroiane/piperaquine combination

 

9.30 - 10.00

 

Assured Artemisinin Supply System (A2S2)

  • Project Update
  • Project Extension, including discussions on the creation of country and international sector groups/industry associations
 

10.00 - 10.30

 

New Developments in High Yielding Artemisia Varieties and Production Methods

 

10.30 - 11.00

 

Proposed changes to specifications for Artemisinin as an API and a Starting Material

 

11.00

 

Tea/Coffee Break served in Break Out Sessions

   

11.00 - 13.00

 
 

1) Break Out Session on Stabilising Artemisinin/API/ACT Supply

Market demand/timing, and Artemisinin/API/ACT production planning

 

 

Chairs/Rapporteurs – Andrea Bosman and Jan Van Erps

 

2) Break Out Session on Technical Issues and Developments:

High Yielding Artemisia Varieties; Artemisinin Extraction, Purification; Artemisinin Analysis and Quality Requirements as Starting Material; Derivitisation

 

Chairs/Rapporteurs – Anthony Ellman and Bhupinder Khambay

13.00 - 14.00

 

Lunch

   

14.00 - 15.30

 

Presentations of conclusions and key findings of the Break Out Sessions and Conference

 

Break Out Chairs/Rapporteurs

15.30 - 16.00

 

Tea/Coffee Break

   

16.00 - 17.00

 

General discussions and development of consensus on next steps

   

17.00

 

Closure

   

Day 3, 17th January

Field Visit

Around 40 delegates from the Artemisinin Conference made the ca. two hour trip north of Nairobi to visit a large estate (Marula farm) near Naivasha, where Artemisia is cultivated by Elysian Life Sciences and managed by Botanical Extracts. During the visit, the visitors were taken around the plantation by company representatives and were able to view the local workers in action; recently planted Artemisia; and also Artemisia being harvested.

To view the photo gallery of the trip, click here.